• 1
    Chang G. Multidrug resistance ABC transporters. FEBS Lett 2003; 555: 1025.
  • 2
    Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000; 11: 26583.
  • 3
    Childs S, Ling V. The MDR superfamily of genes and its biological implications. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia: Lippincott, 1994; 2136.
  • 4
    Chen C, Chin JE, Ueda K et al . Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 3819.
  • 5
    Ling V, Thompson LH. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 1974; 83: 10316.
  • 6
    Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene 2003; 22: 746885.
  • 7
    Ho Y, Sheu LF, Ng JA, Hsu SM. Establishment and characterisation of an Epstein–Barr virus negative B immunoblastic lymphoma cell line. Br J Cancer 1990; 61: 6558.
  • 8
    Chao C. Cross-resistance to cis-diamminedichloroplatinum (II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair. Eur J Pharmacol 1996; 305: 21322.
  • 9
    Wyllie A, Ha DE. Cell injury and death. In: McGee J, Isaacson PJ, Wright NA, eds. Oxford Textbook of Pathology. Oxford: Oxford University Press, 1992; 141152.
  • 10
    Lockshin R, Zakeri Z. Caspase-independent cell death? Oncogene 2004; 23: 276673.
  • 11
    Guenal I, Sidoti-de Fraisse C, Gaumer S, Mignotte B. Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene 1997; 15: 34760.
  • 12
    Clement M, Pervaiz S. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: an hypothesis. Free Radic Res 1999; 30: 24752.
  • 13
    Moghaddas S, Hoppel CL, Lesnefsky EJ. Aging defect at the QO site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch Biochem Biophys 2003; 414: 5966.
  • 14
    Pamplona R, Portero-Otin M, Bellmun MJ, Gredilla R, Barja G. Aging increases Nepsilon-(carboxymethyl) lysine and caloric restriction decreases Nepsilon-(carboxyethyl) lysine and Nepsilon-(malondialdehyde) lysine in rat heart mitochondrial proteins. Free Radic Res 2002; 36: 4754.
  • 15
    Ardies C. Inflammation as cause for scar cancers of the lung. Integr Cancer Ther 2003; 2: 23846.
  • 16
    Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst) 2004; 3: 110915.
  • 17
    Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004; 337: 113.
  • 18
    Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000; 29: 32333.
  • 19
    Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002; 84: 13141.
  • 20
    Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996; 313: 1729.
  • 21
    LeBel C, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5: 22731.
  • 22
    Carter W, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 1994; 55: 2538.
  • 23
    Sun NK, Kamarajan P, Huang H, Chao CC. Restoration of UV sensitivity in UV-resistant HeLa cells by antisense-mediated depletion of damaged DNA-binding protein 2 (DDB2). FEBS Lett 2002; 512: 16872.
  • 24
    Chao C, Huang SL, Huang HM, Lin-Chao S. Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA. Mol Cell Biol 1991; 11: 207580.
  • 25
    Kamarajan P, Sun NK, Sun CL, Chao CC. Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line. FEBS Lett 2001; 505: 20612.
  • 26
    Wyllie A, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 6777.
  • 27
    Darzynkiewicz Z, Li X. Measurements of Cell Death by Flow Cytometry. London: Portland Press, 1996.
  • 28
    Martin SJ, Reutelingsperger CPM, McGahon AJ et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.J. Exp. Med. 1995; 182: 154556.
  • 29
    Chiu D, Lubin B. Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: evidence for increased susceptibility to lipid peroxidation in vivo. J Laboratory Clin Med 1979; 94: 5428.
  • 30
    Chiu D, Stults FH, Tappel AL. Purification and properties of rat lung soluble glutathione peroxidase. Biochim Biophys Acta 1976; 445: 55866.
  • 31
    Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 1216.
  • 32
    Lakritz J, Plopper CG, Buckpitt AR. Validated high-performance liquid chromatography-electrochemical method for determination of glutathione and glutathione disulfide in small tissue samples. Anal Biochem 1997; 247: 638.
  • 33
    Smith N, Dunnett M, Mills PC. Simultaneous quantitation of oxidised and reduced glutathione in equine biological fluids by reversed-phase high-performance liquid chromatography using electrochemical detection. J Chromatogr B Biomed Appl 1995; 673: 3541.
  • 34
    Debatin K, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene 2004; 23: 295066.
  • 35
    Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001; 98: 260314.
  • 36
    Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 2002; 50: 34352.
  • 37
    Jordan M, Himes RH, Wilson L. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res 1985; 45: 27417.
  • 38
    Jordan M, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 1991; 51: 221222.
  • 39
    Groninger E, Meeuwsen-De Boer GJ, De Graaf SS, Kamps WA, De Bont ES. Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species? Int J Oncol 2002; 21: 133945.
  • 40
    McCurrach M, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 1997; 94: 23459.
  • 41
    Schmitt C, Rosenthal CT, Lowe SW. Genetic analysis of chemoresistance in primary murine lymphomas. Nat Med 2000; 6: 102935.
  • 42
    Tohyama Y, Takano T, Yamamura H. B cell responses to oxidative stress. Curr Pharm Des 2004; 10: 8359.
  • 43
    Jang J, Surh YJ. Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem Pharmacol 2003; 66: 13719.
  • 44
    Miyamoto Y, Koh YH, Park YS et al . Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol Chem 2003; 384: 56774.
  • 45
    Paumi CMLBG, Smitherman PK, Townsend AJ, Morrow CS. Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity. J Biol Chem 2000; 276: 79526.
  • 46
    Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003; 60: 620.
  • 47
    Kobrinsky NL, Sjolander DE, Goldenberg JA, Ortmeier TC. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith–Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue. Pediatr Blood Cancer 2005; 45: 2225.
  • 48
    Akan I, Akan S, Akca H, Savas B, Ozben T. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and buthionine sulfoximine. Cancer Cell Int 2005; 5: 22.
  • 49
    Aizawa SOK, Kudo T, Asano J, Hayakari M, Tsuchida S. Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-l-cysteine. Cancer Sci 2003; 94: 88693.